View More Recent Stories
-
Raymond James Downgrades Teleflex (TFX) to Market Perform
-
Piper Sandler Downgrades Teleflex (TFX) to Neutral
-
Teleflex (TFX) call put ratio 3.7 calls to 1 put as share price down 22%
-
Teleflex (TFX) Declares $0.34 Quarterly Dividend; 0.8% Yield
-
Teleflex (TFX) Tops Q4 EPS by 3c ; Offers Guidance
-
Teleflex (TFX) Announces CFO Change
-
Teleflex (TFX) to Separate into Two Publicly Traded Companies
-
Teleflex (TFX) to Acquire BIOTRONIK’s Vascular Intervention Business
-
Pulse Biosciences, Inc. (PLSE) Appoints Jon Skinner as CFO
-
Teleflex (TFX) PT Lowered to $230 at Mizuho
-
Needham Reiterates Hold Rating on Teleflex (TFX)
-
Teleflex (TFX) in Talks to Buy German Biotronik’s Stent Unit - Bloomberg
-
Teleflex (TFX) PT Lowered to $274 at CL King, 'Sell-off Was Overdone'
-
Teleflex (TFX) PT Lowered to $227 at Truist Securities
-
Teleflex (TFX) PT Lowered to $227 at Truist Securities
-
Morgan Stanley Defending Teleflex (TFX), 'Stock Reaction Overdone'
-
Teleflex (TFX) Declares $0.34 Quarterly Dividend; 0.6% Yield
-
Teleflex (TFX) Tops Q3 EPS by 10c, provides guidance
-
Teleflex (TFX) Presents New Barrigel Rectal Spacer Data
-
Teleflex (TFX) Announces Publication of Propensity Matching Review of Retrospective Data Reporting that Titan SGS Stapler Enables Consistent Gastric Pouch Formation with Fewer Variations
-
Teleflex (TFX) Declares $0.34 Quarterly Dividend; 0.6% Yield
-
Teleflex (TFX) Tops Q2 EPS by 9c, provides guidance
-
Teleflex (TFX) Announces the Teleflex Center for Antimicrobial Protection
-
Teleflex (TFX) PT Raised to $240 at Truist Securities
-
Teleflex (TFX) PT Raised to $235 at Truist Securities
-
Teleflex (TFX) option IV flat amid price moving up

